Menu
Recruiting NCT06345976

Functional Impairment in Albinism

Observational Albinism, Ocular

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: questionnaire.
Who it may be relevant to
Registry conditions: Albinism, Ocular. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Albinism is a genetic and hereditary anomaly that affects pigmentation. This pathology is characterized by a deficit in melanin production. In humans, the clinical diagnosis of albinism is based on a number of factors, including : * In the integumentary region: fair skin tone, with white hair, eyelashes and eyebrows. * Ophthalmological: reduced visual acuity, photophobia, nystagmus, transilluminated blue irises, hypopigmentation of the retina at the back of the eye with fovea plana. As treatment options begin to emerge for certain albinism-induced anomalies (including, for example, the depigmentation that causes photophobia), it is desirable to understand what these patients' complaints are, and to gather their views on the emergence of treatments targeting just one of their complaints, namely glare.

Interventions

  • Other questionnaire
    On-line self-questionnaire, in the form of an 18-question form, the link to which is sent by e-mail to patients with albinism who have agreed to take part in the study.

Primary outcome measures

  • To determine whether patients with albinism would be interested in a treatment that could improve their glare without improving their visual acuity. [Time frame: Day0]

Eligibility criteria

Inclusion criteria

  • All patients with albinism
  • Patients > 18 years of age
  • Non-opposition to study participation

Exclusion criteria

No diagnosis according to Kruijt et al. criteria Impossibility (visual, technological) of completing questionnaire

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

France · 1 center
  • Hôpital Fondation A. de Rothschild — Paris

Identifiers

NCT: NCT06345976 · RLX_2023_10

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗